• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
GUAN Yitong, HU Pengwei, ZOU Wenyu, LU Yuting, SONG Min, HANG Taijun. Determination of formaldehyde and glyoxal in varenicline tartrate using derivative method with HPLC[J]. Journal of China Pharmaceutical University, 2021, 52(3): 332-338. DOI: 10.11665/j.issn.1000-5048.20210310
Citation: GUAN Yitong, HU Pengwei, ZOU Wenyu, LU Yuting, SONG Min, HANG Taijun. Determination of formaldehyde and glyoxal in varenicline tartrate using derivative method with HPLC[J]. Journal of China Pharmaceutical University, 2021, 52(3): 332-338. DOI: 10.11665/j.issn.1000-5048.20210310
shu

Determination of formaldehyde and glyoxal in varenicline tartrate using derivative method with HPLC

  • Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing 210009, China

Funds: This study was supported by the Open Project of Key Laboratory of Related Substances of Chemical Medicines of Jiangsu Institute for Food and Drug Control (No.NMPA-KLIPCD-2020-03)
More Information
  • Received Date: January 08, 2021
  • Revised Date: May 09, 2021
    Graphical Abstract
    • Abstract
  • To establish a method for the determination of formaldehyde and glyoxal simultaneously in varenicline tartrate active pharmaceutical ingredient (API) and its intermediate, formaldehyde and glyoxal were derivatized by 2, 4-dinitrophenylhydrazine (2,4-DNPH) to improve the HPLC retention and UV detection sensitivity. Separation was performed on a C8 (150 mm × 4.6 mm, 5 μm) column by linear gradient elution using acetonitrile and water as the mobile phase; the detective wavelength was set at 380 nm.Formaldehyde and glyoxal were quantitatively determined by an external reference method.Linear calibration was established for both formaldehyde and glyoxal in the range from 0.094 to 1.88 μg/mL.The detection and the quantification limits were 0.047 μg/mL (19 μg/g) and 0.094 μg/mL (38 μg/g), respectively.The recoveries were (95.0±1.1)% and (99.4 ± 2.6)% for formaldehyde and glyoxal, respectively.This method has been fully validated to be applicable to quantitative analysis of trace amount of formaldehyde and glyoxal in varenicline tartrate API and its intermediate.Test results demonstrated that the contents of both formaldehyde and glyoxal met the permitted daily exposure (PDE) limits for the finished products of varenicline tartrate API as well as its intermediate, though the glyoxal contents in the crude intermediates were likely to exceed the limit.The established method is valuable for the manufacturing process and quality control of varenicline tartrate.
    • FullText(HTML)
    • References (16)
  • [1]
    . PLoS One，2020，15（4）：e0231095.
    [2]
    Song F，Song XN，Wang L，et al. Determination of six aniline-like genotoxic impurities in varenicline tartrate by LC-MS［J］. Chin J Pharm Anal（药物分析杂志），2018，38（1）：130-134.
    [3]
    Li YF，Wu XM. Synthesis and application research progress of glyoxal［J］. Fine Specialty Chem（精细与专用化学品），2020，28（3）：36-38.
    [4]
    Bernardini L，Barbosa E，Char?o MF，et al. Formaldehyde toxicity reports from in vitro and in vivo studies：a review and updated data［J］. Drug Chem Toxicol，2020：1-13.doi：10.1080/01480545.2020.1795190.
    [5]
    Barnett BM，Mu?oz ER. Effect of glyoxal pretreatment on radiation-induced genetic damage in Drosophila melanogaster［J］. Mutat Res Mol Mech Mutagen，1989，212（2）：173-179.
    [6]
    del Barrio MA，Hu J，Zhou PZ，et al. Simultaneous determination of formic acid and formaldehyde in pharmaceutical excipients using headspace GC/MS［J］. J Pharm Biomed Anal，2006，41（3）：738-743.
    [7]
    M7（R1）：Assessment and control of DNA reactive （mutagenic） impurities in pharmaceuticals to limit potential carcinogenic risk［S］：Brussels：ICH，2017：36.
    [8]
    EMA（European Medicines Agency）.Guidelines on the Limits of Genotoxic Impurities［S/OL］.（2006-06-28）［2019-01］.http：//www.EMA.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002903.pdf.
    [9]
    CHMP Safety Working Party.Question & Answers on the
    CHMP Guideline on Limits of Genotoxic Impurities    ［S/OL］.（2009-12）［2019-01］.http：//www.EMA.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002907.pdf.
    [10]
    Chinese Pharmacopoeia Commission.Chinese Pharmacopoeia：part 4（中华人民共和国药典：四部）［S］. Beijing：China Medical Science Press，2020.
    [11]
    Jiang Y，Wang J，Xu K，et al. Research on blank interference and method optimization for determination of formaldehyde and aldehyde in pharmaceutical excipients by HPLC with pre-column derivatization［J］. Chin J Pharm Anal（药物分析杂志），2020，40（11）：2062-2069.
    [12]
    Zhou T，Zeng S.Quantitative analysis of trace amount of formaldehyde and formic acid in hydrochlorothiazide API using ethanol derivative method with headspace gas chromatography［J］.Chin J Pharm Anal （药物分析杂志），2017，37 （5）：862-868.
    [13]
    Wang YP，Peng PY，Zhou YM. UV-spectrophotometric determination of glyoxylic acid and glyoxal［J］. Phys Test Chem Anal Part B Chem Anal（理化检验 化学分册），2005，41 （3）：199-202.
    [14]
    Chen XM，Li T. Simultaneous determination of glyoxal and formaldehyde content in food paper packages［J］. Packag Food Mach（包装与食品机械），2020，38（5）：64-67.
    [15]
    Bicking MKL，Marcus Cooke W，Kawahara FK，et al. Effect of pH on the reaction of 2，4-dinitrophenylhydrazine with formaldehyde and acetaldehyde［J］. J Chromatogr A，1988，455：310-315.
    [16]
    China National Textile And Apparel Council.
    GB/T 2912.3-2009.Textiles-Determination of formaldehyde-Part 3：High performance liquid chromatography method（纺织品-甲醛的测定-第三部分：高效液相色谱法）    ［S］：Beijing：General Administration of Quality Supervision，Inspection and Quarantine of the People''s Republic of China，2009：4.
    • Related Articles

  • Related Articles

    [1]HOU Kai, LI Ping, ZHANG Jinlian, WANG Fang, YANG Yu. Blood coagulation factor XI: new strategy of targeted anticoagulant therapy[J]. Journal of China Pharmaceutical University, 2024, 55(5): 708-714. DOI: 10.11665/j.issn.1000-5048.2023050101
    [2]YE Zhenning, WU Zhenghong, ZHANG Huaqing. Research progress of blood-brain barrier crossing strategies and brain-targeted drug delivery mediated by nano-delivery system[J]. Journal of China Pharmaceutical University, 2024, 55(5): 590-602. DOI: 10.11665/j.issn.1000-5048.2024052202
    [3]LIU Yanhong, CHEN Liqing, ZHANG Xintong, GAO Zhonghao, HUANG Wei. Research progress of tumor immunomodulation strategies based on nanodrug delivery system[J]. Journal of China Pharmaceutical University, 2023, 54(1): 5-14. DOI: 10.11665/j.issn.1000-5048.2023021501
    [4]WANG Yanmei, YANG Lei, XIN Xiaofei, YIN Lifang. Combination therapy and drug delivery strategies for treatment of non-alcoholic fatty liver disease[J]. Journal of China Pharmaceutical University, 2022, 53(4): 423-432. DOI: 10.11665/j.issn.1000-5048.20220405
    [5]ZHOU Xinyuan, LIU Nan, ZHANG Pan, HUO Meirong. Advances in research on therapeutic strategies of targeting pancreatic cancer stroma[J]. Journal of China Pharmaceutical University, 2021, 52(6): 653-662. DOI: 10.11665/j.issn.1000-5048.20210602
    [6]FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406
    [7]YANG Shan, XU Cheng, YAO Jing. Strategies of nano drug delivery system applied in anti-angiogenic therapy[J]. Journal of China Pharmaceutical University, 2019, 50(1): 11-18. DOI: 10.11665/j.issn.1000-5048.20190102
    [8]SONG Ke, PAN Hao, HAN Jiayi, CHEN Lijiang. Nano drug delivery system based strategies to target tumor microenvironment[J]. Journal of China Pharmaceutical University, 2018, 49(4): 392-400. DOI: 10.11665/j.issn.1000-5048.20180402
    [9]SU Zhigui, MO Ran, ZHANG Can. Advances of nano-drug delivery systems overcoming the physiological and pathological barriers of tumor[J]. Journal of China Pharmaceutical University, 2015, 46(1): 28-39. DOI: 10.11665/j.issn.1000-5048.20150103
    [10]KE Xue. Advances in targeted drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(1): 9-15.

  • Cited by

    Periodical cited type(2)

    1. 翟允耀，章晓骅. 化学仿制药制剂开发中晶型研究思路探讨. 药品评价. 2024(02): 131-133 .
    2. 梁霖霖，王志伟，何小双，衡伟利，钱帅，高缘，张建军，魏元锋. 机械外力对中药提取物晶体学固态形式及溶出速率的影响研究——以女贞子提取物为例. 中国药科大学学报. 2024(06): 767-774 . 本站查看

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (317) PDF downloads (773) Cited by(2)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：365829

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return